{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T03:08:30Z","timestamp":1790651310632,"version":"4.1.0"},"reference-count":166,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,3,25]],"date-time":"2023-03-25T00:00:00Z","timestamp":1679702400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,25]],"date-time":"2023-03-25T00:00:00Z","timestamp":1679702400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Manipal Academy of Higher Education, Manipal"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2023,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The \u201cThalidomide tragedy\u201d is a landmark in the history of the pharmaceutical industry. Despite limited clinical trials, there is a continuous effort to investigate thalidomide as a drug for cancer and inflammatory diseases such as rheumatoid arthritis, lepromatous leprosy, and COVID-19. This review focuses on the possibilities of targeting inflammation by repurposing thalidomide for the treatment of idiopathic pulmonary fibrosis (IPF). Articles were searched from the Scopus database, sorted, and selected articles were reviewed. The content includes the proven mechanisms of action of thalidomide relevant to IPF. Inflammation, oxidative stress, and epigenetic mechanisms are major pathogenic factors in IPF. Transforming growth factor-\u03b2 (TGF-\u03b2) is the major biomarker of IPF. Thalidomide is an effective anti-inflammatory drug in inhibiting TGF-\u03b2, interleukins (IL-6 and IL-1\u03b2), and tumour necrosis factor-\u03b1 (TNF-\u03b1). Thalidomide binds cereblon, a process that is involved in the proposed mechanism in specific cancers such as breast cancer, colon cancer, multiple myeloma, and lung cancer. Cereblon is involved in activating AMP-activated protein kinase (AMPK)-TGF-\u03b2\/Smad signalling, thereby attenuating fibrosis. The past few years have witnessed an improvement in the identification of biomarkers and diagnostic technologies in respiratory diseases, partly because of the COVID-19 pandemic. Hence, investment in clinical trials with a systematic plan can help repurpose thalidomide for pulmonary fibrosis.<\/jats:p>\n                  <jats:p>\n                    <jats:bold>Graphical Abstract<\/jats:bold>\n                  <\/jats:p>","DOI":"10.1007\/s10787-023-01193-1","type":"journal-article","created":{"date-parts":[[2023,3,25]],"date-time":"2023-03-25T15:02:48Z","timestamp":1679756568000},"page":"1167-1182","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Thalidomide interaction with inflammation in idiopathic pulmonary fibrosis"],"prefix":"10.1007","volume":"31","author":[{"given":"Nikitha Naomi","family":"Dsouza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varun","family":"Alampady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishnaprasad","family":"Baby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swastika","family":"Maity","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bharath Harohalli","family":"Byregowda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0508-1394","authenticated-orcid":false,"given":"Yogendra","family":"Nayak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,25]]},"reference":[{"key":"1193_CR1","doi-asserted-by":"publisher","first-page":"104296","DOI":"10.1016\/j.ebiom.2022.104296","volume":"85","author":"M Ackermann","year":"2022","unstructured":"Ackermann M, Kamp JC, Werlein C et al (2022) The fatal trajectory of pulmonary COVID-19 is driven by lobular ischemia and fibrotic remodelling. EBioMedicine 85:104296. https:\/\/doi.org\/10.1016\/j.ebiom.2022.104296","journal-title":"EBioMedicine"},{"key":"1193_CR2","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s10456-017-9543-z","volume":"20","author":"M Ackermann","year":"2017","unstructured":"Ackermann M, Kim YO, Wagner WL et al (2017) Effects of nintedanib on the microvascular architecture in a lung fibrosis model. Angiogenesis 20:359\u2013372. https:\/\/doi.org\/10.1007\/s10456-017-9543-z","journal-title":"Angiogenesis"},{"key":"1193_CR3","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.jaci.2016.06.033","volume":"138","author":"M Akdis","year":"2016","unstructured":"Akdis M, Aab A, Altunbulakli C et al (2016) Interleukins (from IL-1 to IL-38), interferons, transforming growth factor \u03b2, and TNF-\u03b1: Receptors, functions, and roles in diseases. J Allergy Clin Immunol 138:984\u20131010. https:\/\/doi.org\/10.1016\/j.jaci.2016.06.033","journal-title":"J Allergy Clin Immunol"},{"key":"1193_CR4","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1007\/s10787-022-01027-6","volume":"30","author":"HM Al-kuraishy","year":"2022","unstructured":"Al-kuraishy HM, Batiha GE-S, Faidah H et al (2022) Pirfenidone and post-Covid-19 pulmonary fibrosis: invoked again for realistic goals. Inflammopharmacology 30:2017\u20132026. https:\/\/doi.org\/10.1007\/s10787-022-01027-6","journal-title":"Inflammopharmacology"},{"key":"1193_CR5","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1177\/1078155220975825","volume":"27","author":"GG Amare","year":"2021","unstructured":"Amare GG, Meharie BG, Belayneh YM (2021) A drug repositioning success: the repositioned therapeutic applications and mechanisms of action of thalidomide. J Oncol Pharm Pract 27:673\u2013678. https:\/\/doi.org\/10.1177\/1078155220975825","journal-title":"J Oncol Pharm Pract"},{"key":"1193_CR6","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.intimp.2013.06.005","volume":"17","author":"K Amirshahrokhi","year":"2013","unstructured":"Amirshahrokhi K (2013) Anti-inflammatory effect of thalidomide in paraquat-induced pulmonary injury in mice. Int Immunopharmacol 17:210\u2013215. https:\/\/doi.org\/10.1016\/j.intimp.2013.06.005","journal-title":"Int Immunopharmacol"},{"key":"1193_CR7","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1007\/s10753-014-9953-7","volume":"38","author":"K Amirshahrokhi","year":"2015","unstructured":"Amirshahrokhi K, Khalili A-R (2015) Thalidomide ameliorates cisplatin-induced nephrotoxicity by inhibiting renal inflammation in an experimental model. Inflammation 38:476\u2013484. https:\/\/doi.org\/10.1007\/s10753-014-9953-7","journal-title":"Inflammation"},{"key":"1193_CR8","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1267\/ahc.10030","volume":"44","author":"H Arai","year":"2011","unstructured":"Arai H, Furusu A, Nishino T et al (2011) Thalidomide prevents the progression of peritoneal fibrosis in mice. Acta Histochem Cytochem 44:51\u201360. https:\/\/doi.org\/10.1267\/ahc.10030","journal-title":"Acta Histochem Cytochem"},{"key":"1193_CR9","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1038\/s41589-019-0366-7","volume":"15","author":"T Asatsuma-Okumura","year":"2019","unstructured":"Asatsuma-Okumura T, Ando H, De Simone M et al (2019a) p63 is a cereblon substrate involved in thalidomide teratogenicity. Nat Chem Biol 15:1077\u20131084. https:\/\/doi.org\/10.1038\/s41589-019-0366-7","journal-title":"Nat Chem Biol"},{"key":"1193_CR10","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.pharmthera.2019.06.004","volume":"202","author":"T Asatsuma-Okumura","year":"2019","unstructured":"Asatsuma-Okumura T, Ito T, Handa H (2019b) Molecular mechanisms of cereblon-based drugs. Pharmacol Ther 202:132\u2013139. https:\/\/doi.org\/10.1016\/j.pharmthera.2019.06.004","journal-title":"Pharmacol Ther"},{"key":"1193_CR11","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3390\/ph13050095","volume":"13","author":"T Asatsuma-Okumura","year":"2020","unstructured":"Asatsuma-Okumura T, Ito T, Handa H (2020) Molecular mechanisms of the teratogenic effects of thalidomide. Pharmaceuticals 13:95. https:\/\/doi.org\/10.3390\/ph13050095","journal-title":"Pharmaceuticals"},{"key":"1193_CR12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2174\/0929867328666210623143526","volume":"29","author":"A Barbarossa","year":"2022","unstructured":"Barbarossa A, Iacopetta D, Sinicropi MS et al (2022) Recent advances in the development of thalidomide-related compounds as anticancer drugs. Curr Med Chem 29:19\u201340. https:\/\/doi.org\/10.2174\/0929867328666210623143526","journal-title":"Curr Med Chem"},{"key":"1193_CR13","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3390\/jcm7080201","volume":"7","author":"S Barratt","year":"2018","unstructured":"Barratt S, Creamer A, Hayton C, Chaudhuri N (2018) Idiopathic pulmonary fibrosis (IPF): an overview. J Clin Med 7:201. https:\/\/doi.org\/10.3390\/jcm7080201","journal-title":"J Clin Med"},{"key":"1193_CR14","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/J.VPH.2015.07.003","volume":"92","author":"T Behl","year":"2017","unstructured":"Behl T, Kaur I, Goel H, Kotwani A (2017) Significance of the antiangiogenic mechanisms of thalidomide in the therapy of diabetic retinopathy. Vascul Pharmacol 92:6\u201315. https:\/\/doi.org\/10.1016\/J.VPH.2015.07.003","journal-title":"Vascul Pharmacol"},{"key":"1193_CR15","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S2213-2600(20)30356-8","volume":"9","author":"J Behr","year":"2021","unstructured":"Behr J, Nathan SD, Wuyts WA et al (2021) Efficacy and safety of sildenafil added to pirfenidone in patients with advanced idiopathic pulmonary fibrosis and risk of pulmonary hypertension: a double-blind, randomised, placebo-controlled, phase 2b trial. Lancet Respir Med 9:85\u201395. https:\/\/doi.org\/10.1016\/S2213-2600(20)30356-8","journal-title":"Lancet Respir Med"},{"key":"1193_CR16","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/fcp.12162","volume":"30","author":"LE Bersani-Amado","year":"2016","unstructured":"Bersani-Amado LE, Dantas JA, Dami\u00e3o MJ et al (2016) Involvement of cytokines in the modulation and progression of renal fibrosis induced by unilateral ureteral obstruction in C57BL\/6 mice: effects of thalidomide and dexamethasone. Fundam Clin Pharmacol 30:35\u201346. https:\/\/doi.org\/10.1111\/fcp.12162","journal-title":"Fundam Clin Pharmacol"},{"key":"1193_CR17","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.freeradbiomed.2018.10.423","volume":"129","author":"C Bian","year":"2018","unstructured":"Bian C, Qin W-J, Zhang C-Y et al (2018) Thalidomide (THD) alleviates radiation induced lung fibrosis (RILF) via down-regulation of TGF-\u03b2\/Smad3 signaling pathway in an Nrf2-dependent manner. Free Radic Biol Med 129:446\u2013453. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2018.10.423","journal-title":"Free Radic Biol Med"},{"key":"1193_CR18","first-page":"1640","volume":"29","author":"G Blaschke","year":"1979","unstructured":"Blaschke G, Kraft HP, Fickentscher K, K\u00f6hler F (1979) Chromatographic separation of racemic thalidomide and teratogenic activity of its enantiomers. Arzneimittel-Forschung\/drug Res 29:1640\u20131642","journal-title":"Arzneimittel-Forschung\/drug Res"},{"key":"1193_CR19","doi-asserted-by":"publisher","first-page":"5324","DOI":"10.1038\/s41467-022-33063-9","volume":"13","author":"M Bobowski-Gerard","year":"2022","unstructured":"Bobowski-Gerard M, Boulet C, Zummo FP et al (2022) Functional genomics uncovers the transcription factor BNC2 as required for myofibroblastic activation in fibrosis. Nat Commun 13:5324. https:\/\/doi.org\/10.1038\/s41467-022-33063-9","journal-title":"Nat Commun"},{"key":"1193_CR20","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s40264-016-0501-2","volume":"40","author":"NA Brandenburg","year":"2017","unstructured":"Brandenburg NA, Bwire R, Freeman J et al (2017) Effectiveness of risk evaluation and mitigation strategies (REMS) for lenalidomide and thalidomide: patient comprehension and knowledge retention. Drug Saf 40:333\u2013341. https:\/\/doi.org\/10.1007\/s40264-016-0501-2","journal-title":"Drug Saf"},{"key":"1193_CR21","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/J.MATBIO.2018.03.015","volume":"68\u201369","author":"A Burman","year":"2018","unstructured":"Burman A, Tanjore H, Blackwell TS (2018) Endoplasmic reticulum stress in pulmonary fibrosis. Matrix Biol 68\u201369:355. https:\/\/doi.org\/10.1016\/J.MATBIO.2018.03.015","journal-title":"Matrix Biol"},{"key":"1193_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2020.581828","author":"P Cameli","year":"2020","unstructured":"Cameli P, Refini RM, Bergantini L et al (2020) Long-term follow-up of patients with idiopathic pulmonary fibrosis treated with pirfenidone or nintedanib: a real-life comparison study. Front Mol Biosci. https:\/\/doi.org\/10.3389\/fmolb.2020.581828","journal-title":"Front Mol Biosci"},{"key":"1193_CR23","first-page":"287","volume":"2","author":"X-B Chang","year":"2011","unstructured":"Chang X-B, Keith Stewart A (2011) What is the functional role of the thalidomide binding protein cereblon? Int J Biochem Mol Biol 2:287\u2013294","journal-title":"Int J Biochem Mol Biol"},{"key":"1193_CR24","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1002\/ctm2.35","volume":"10","author":"C Chen","year":"2020","unstructured":"Chen C, Qi F, Shi K et al (2020) Thalidomide combined with low-dose short-term glucocorticoid in the treatment of critical Coronavirus Disease 2019. Clin Transl Med 10:e35. https:\/\/doi.org\/10.1002\/ctm2.35","journal-title":"Clin Transl Med"},{"key":"1193_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.01486","author":"H Chen","year":"2019","unstructured":"Chen H, Xu H, Luo L et al (2019a) Thalidomide prevented and ameliorated pathogenesis of Crohn\u2019s disease in mice via regulation of inflammatory response and fibrosis. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2019.01486","journal-title":"Front Pharmacol"},{"key":"1193_CR26","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1097\/RCT.0000000000000915","volume":"43","author":"L Chen","year":"2019","unstructured":"Chen L, Halai V, Leandru A, Wallis A (2019b) Interstitial lung disease: update on the role of computed tomography in the diagnosis of idiopathic pulmonary fibrosis. J Comput Assist Tomogr 43:898\u2013905. https:\/\/doi.org\/10.1097\/RCT.0000000000000915","journal-title":"J Comput Assist Tomogr"},{"key":"1193_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.984730","author":"Q Chen","year":"2022","unstructured":"Chen Q, Wang Y, Sheng L, Huang Y (2022) Metformin suppresses proliferation and differentiation induced by BMP9 via AMPK signaling in human fetal lung fibroblast-1. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2022.984730","journal-title":"Front Pharmacol"},{"key":"1193_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12967-021-03036-5\/FIGURES\/9","volume":"19","author":"D Cheng","year":"2021","unstructured":"Cheng D, Xu Q, Wang Y et al (2021) Metformin attenuates silica-induced pulmonary fibrosis via AMPK signaling. J Transl Med 19:1\u201318. https:\/\/doi.org\/10.1186\/S12967-021-03036-5\/FIGURES\/9","journal-title":"J Transl Med"},{"key":"1193_CR29","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s00011-009-0084-9","volume":"59","author":"J-Y Choe","year":"2010","unstructured":"Choe J-Y, Jung H-J, Park K-Y et al (2010) Anti-fibrotic effect of thalidomide through inhibiting TGF-\u03b2-induced ERK1\/2 pathways in bleomycin-induced lung fibrosis in mice. Inflamm Res 59:177\u2013188. https:\/\/doi.org\/10.1007\/s00011-009-0084-9","journal-title":"Inflamm Res"},{"key":"1193_CR30","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.3346\/JKMS.2016.31.9.1419","volume":"31","author":"SM Choi","year":"2016","unstructured":"Choi SM, Jang AH, Kim H et al (2016) Metformin reduces bleomycin-induced pulmonary fibrosis in mice. J Korean Med Sci 31:1419\u20131425. https:\/\/doi.org\/10.3346\/JKMS.2016.31.9.1419","journal-title":"J Korean Med Sci"},{"key":"1193_CR31","doi-asserted-by":"publisher","first-page":"3571","DOI":"10.1523\/JNEUROSCI.2081-17.2018","volume":"38","author":"T-Y Choi","year":"2018","unstructured":"Choi T-Y, Lee S-H, Kim Y-J et al (2018) Cereblon maintains synaptic and cognitive function by regulating BK channel. J Neurosci 38:3571\u20133583. https:\/\/doi.org\/10.1523\/JNEUROSCI.2081-17.2018","journal-title":"J Neurosci"},{"key":"1193_CR32","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1097\/RLI.0000000000000574","volume":"54","author":"A Christe","year":"2019","unstructured":"Christe A, Peters AA, Drakopoulos D et al (2019) Computer-aided diagnosis of pulmonary fibrosis using deep learning and CT images. Invest Radiol 54:627\u2013632. https:\/\/doi.org\/10.1097\/RLI.0000000000000574","journal-title":"Invest Radiol"},{"key":"1193_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00354","author":"M Cinausero","year":"2017","unstructured":"Cinausero M, Aprile G, Ermacora P et al (2017) New frontiers in the pathobiology and treatment of cancer regimen-related mucosal injury. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2017.00354","journal-title":"Front Pharmacol"},{"key":"1193_CR34","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1042\/bio03205036","volume":"32","author":"CR Cooper","year":"2010","unstructured":"Cooper CR, Poindexter C, Rohe B, Sikes RA (2010) Thalidomide and its analogues in prostate cancer therapy\u2014a scientific update. Biochem (lond) 32:36\u201339. https:\/\/doi.org\/10.1042\/bio03205036","journal-title":"Biochem (lond)"},{"key":"1193_CR35","doi-asserted-by":"publisher","first-page":"4082","DOI":"10.1073\/pnas.91.9.4082","volume":"91","author":"RJ D\u2019Amato","year":"1994","unstructured":"D\u2019Amato RJ, Loughnan MS, Flynn E, Folkman J (1994) Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci 91:4082\u20134085. https:\/\/doi.org\/10.1073\/pnas.91.9.4082","journal-title":"Proc Natl Acad Sci"},{"key":"1193_CR36","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.12688\/f1000research.8209.1","volume":"5","author":"C Daccord","year":"2016","unstructured":"Daccord C, Maher TM (2016) Recent advances in understanding idiopathic pulmonary fibrosis. F1000Research 5:1046. https:\/\/doi.org\/10.12688\/f1000research.8209.1","journal-title":"F1000Research"},{"key":"1193_CR37","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1186\/s12931-021-01863-0","volume":"22","author":"ML Decaris","year":"2021","unstructured":"Decaris ML, Schaub JR, Chen C et al (2021) Dual inhibition of \u03b1v\u03b26 and \u03b1v\u03b21 reduces fibrogenesis in lung tissue explants from patients with IPF. Respir Res 22:265. https:\/\/doi.org\/10.1186\/s12931-021-01863-0","journal-title":"Respir Res"},{"key":"1193_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2021.114727","author":"M-Y Deng","year":"2021","unstructured":"Deng M-Y, Ahmad KA, Han Q-Q et al (2021) Thalidomide alleviates neuropathic pain through microglial IL-10\/\u03b2-endorphin signaling pathway. Biochem Pharmacol. https:\/\/doi.org\/10.1016\/j.bcp.2021.114727","journal-title":"Biochem Pharmacol"},{"key":"1193_CR39","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/S2213-2600(18)30007-9","volume":"6","author":"C Denver","year":"2018","unstructured":"Denver C, Eickelberg UO, Schwarz MI, Schwartz DA (2018) Time for a change: is idiopathic pulmonary fibrosis still idiopathic and only fibrotic? Lancet Respir Med 6:154\u2013160. https:\/\/doi.org\/10.1016\/S2213-2600(18)30007-9","journal-title":"Lancet Respir Med"},{"key":"1193_CR40","doi-asserted-by":"publisher","unstructured":"Diaz de Leon A, Cronkhite JT, Katzenstein A-LA, et al (2010) Telomere Lengths, Pulmonary Fibrosis and Telomerase (TERT) Mutations. PLoS One 5:e10680. https:\/\/doi.org\/10.1371\/journal.pone.0010680","DOI":"10.1371\/journal.pone.0010680"},{"key":"1193_CR41","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1159\/000508672","volume":"236","author":"S Domingo","year":"2020","unstructured":"Domingo S, Sol\u00e9 C, Molin\u00e9 T et al (2020) Efficacy of thalidomide in discoid lupus erythematosus: insights into the molecular mechanisms. Dermatology 236:467\u2013476. https:\/\/doi.org\/10.1159\/000508672","journal-title":"Dermatology"},{"key":"1193_CR42","first-page":"4390","volume":"9","author":"X Dong","year":"2017","unstructured":"Dong X, Li X, Li M et al (2017a) Inhibitory effects of thalidomide on bleomycin-induced pulmonary fibrosis in rats via regulation of thioredoxin reductase and inflammations. Am J Transl Res 9:4390\u20134401","journal-title":"Am J Transl Res"},{"key":"1193_CR43","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1007\/s10753-017-0625-2","volume":"40","author":"X Dong","year":"2017","unstructured":"Dong X, Li X, Li M et al (2017b) Antiinflammation and antioxidant effects of thalidomide on pulmonary fibrosis in mice and human lung fibroblasts. Inflammation 40:1836\u20131846. https:\/\/doi.org\/10.1007\/s10753-017-0625-2","journal-title":"Inflammation"},{"key":"1193_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/3564871","volume":"2022","author":"Z Dong","year":"2022","unstructured":"Dong Z, Yin EG, Yang M et al (2022) Role and mechanism of keap1\/nrf2 signaling pathway in the regulation of autophagy in alleviating pulmonary fibrosis. Comput Intell Neurosci 2022:1\u20139. https:\/\/doi.org\/10.1155\/2022\/3564871","journal-title":"Comput Intell Neurosci"},{"key":"1193_CR45","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.biopha.2016.11.063","volume":"85","author":"B El-Aarag","year":"2017","unstructured":"El-Aarag B, Kasai T, Masuda J et al (2017) Anticancer effects of novel thalidomide analogs in A549 cells through inhibition of vascular endothelial growth factor and matrix metalloproteinase-2. Biomed Pharmacother 85:549\u2013555. https:\/\/doi.org\/10.1016\/j.biopha.2016.11.063","journal-title":"Biomed Pharmacother"},{"key":"1193_CR46","doi-asserted-by":"publisher","first-page":"104218","DOI":"10.1016\/j.bioorg.2020.104218","volume":"104","author":"MA El-Zahabi","year":"2020","unstructured":"El-Zahabi MA, Sakr H, El-Adl K et al (2020) Design, synthesis, and biological evaluation of new challenging thalidomide analogs as potential anticancer immunomodulatory agents. Bioorg Chem 104:104218. https:\/\/doi.org\/10.1016\/j.bioorg.2020.104218","journal-title":"Bioorg Chem"},{"key":"1193_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.794997","author":"C Estornut","year":"2022","unstructured":"Estornut C, Milara J, Bayarri MA et al (2022) Targeting oxidative stress as a therapeutic approach for idiopathic pulmonary fibrosis. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2021.794997","journal-title":"Front Pharmacol"},{"key":"1193_CR48","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/2639081","author":"AG Fois","year":"2018","unstructured":"Fois AG, Posadino AM, Giordo R et al (2018) Antioxidant activity mediates pirfenidone antifibrotic effects in human pulmonary vascular smooth muscle cells exposed to sera of idiopathic pulmonary fibrosis patients. Oxid Med Cell Longev. https:\/\/doi.org\/10.1155\/2018\/2639081","journal-title":"Oxid Med Cell Longev"},{"key":"1193_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/antiox9111064","volume":"9","author":"AG Fois","year":"2020","unstructured":"Fois AG, Sotgiu E, Scano V et al (2020) Effects of pirfenidone and nintedanib on markers of systemic oxidative stress and inflammation in patients with idiopathic pulmonary fibrosis: a preliminary report. Antioxidants 9:1\u201315. https:\/\/doi.org\/10.3390\/antiox9111064","journal-title":"Antioxidants"},{"key":"1193_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18488-4","author":"H Furihata","year":"2020","unstructured":"Furihata H, Yamanaka S, Honda T et al (2020) Structural bases of IMiD selectivity that emerges by 5-hydroxythalidomide. Nat Commun. https:\/\/doi.org\/10.1038\/s41467-020-18488-4","journal-title":"Nat Commun"},{"key":"1193_CR51","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1111\/resp.13024","volume":"22","author":"JA Galli","year":"2017","unstructured":"Galli JA, Pandya A, Vega-Olivo M et al (2017) Pirfenidone and nintedanib for pulmonary fibrosis in clinical practice: tolerability and adverse drug reactions. Respirology 22:1171\u20131178. https:\/\/doi.org\/10.1111\/resp.13024","journal-title":"Respirology"},{"key":"1193_CR52","doi-asserted-by":"publisher","first-page":"110114","DOI":"10.1016\/j.biopha.2020.110114","volume":"127","author":"S Gao","year":"2020","unstructured":"Gao S, Wang S, Fan R, Hu J (2020) Recent advances in the molecular mechanism of thalidomide teratogenicity. Biomed Pharmacother 127:110114. https:\/\/doi.org\/10.1016\/j.biopha.2020.110114","journal-title":"Biomed Pharmacother"},{"key":"1193_CR53","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1177\/039463201002300422","volume":"23","author":"N Giordano","year":"2010","unstructured":"Giordano N, Puccetti L, Papakostas P et al (2010) Bosentan treatment for Raynauds phenomenon and skin fibrosis in patients with systemic sclerosis and pulmonary arterial hypertension: an open-label, observational, retrospective study. Int J Immunopathol Pharmacol 23:1185\u20131194. https:\/\/doi.org\/10.1177\/039463201002300422","journal-title":"Int J Immunopathol Pharmacol"},{"key":"1193_CR54","doi-asserted-by":"publisher","DOI":"10.1111\/crj.13466","author":"DS Glass","year":"2022","unstructured":"Glass DS, Grossfeld D, Renna HA et al (2022) Idiopathic pulmonary fibrosis: current and future treatment. Clin Respir J. https:\/\/doi.org\/10.1111\/crj.13466","journal-title":"Clin Respir J"},{"key":"1193_CR55","doi-asserted-by":"publisher","first-page":"105844","DOI":"10.1016\/J.PHRS.2021.105844","volume":"173","author":"X Gu","year":"2021","unstructured":"Gu X, Han YY, Yang CY et al (2021) Activated AMPK by metformin protects against fibroblast proliferation during pulmonary fibrosis by suppressing FOXM1. Pharmacol Res 173:105844. https:\/\/doi.org\/10.1016\/J.PHRS.2021.105844","journal-title":"Pharmacol Res"},{"key":"1193_CR56","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1002\/art.1780271006","volume":"27","author":"O Guti\u00e9rrez-Rodr\u00edguez","year":"1984","unstructured":"Guti\u00e9rrez-Rodr\u00edguez O (1984) Thalidomide a promising new treatment for rheumatoid arthritis. Arthritis Rheum 27:1118\u20131121. https:\/\/doi.org\/10.1002\/art.1780271006","journal-title":"Arthritis Rheum"},{"key":"1193_CR57","first-page":"158","volume":"16","author":"O Gutierrez-Rodriguez","year":"1989","unstructured":"Gutierrez-Rodriguez O, Starusta-Bacal P, Gutierrez-Montes O (1989) Treatment of refractory rheumatoid arthritis - the thalidomide experience. J Rheumatol 16:158\u2013163","journal-title":"J Rheumatol"},{"key":"1193_CR58","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/BF02054255","volume":"5","author":"MH Hamza","year":"1986","unstructured":"Hamza MH (1986) Treatment of Beh\u00e7et\u2019s disease with thalidomide. Clin Rheumatol 5:365\u2013371. https:\/\/doi.org\/10.1007\/BF02054255","journal-title":"Clin Rheumatol"},{"key":"1193_CR59","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/dvdy.10150","volume":"225","author":"JM Hansen","year":"2002","unstructured":"Hansen JM, Gong S-G, Philbert M, Harris C (2002) Misregulation of gene expression in the redox-sensitive NF-?b-dependent limb outgrowth pathway by thalidomide. Dev Dyn 225:186\u2013194. https:\/\/doi.org\/10.1002\/dvdy.10150","journal-title":"Dev Dyn"},{"key":"1193_CR60","doi-asserted-by":"publisher","first-page":"E687","DOI":"10.1097\/MJT.0000000000000695","volume":"25","author":"R Haraf","year":"2018","unstructured":"Haraf R, Flora AS, Assaly R (2018) Thalidomide as a cough suppressant in idiopathic pulmonary fibrosis. Am J Ther 25:E687\u2013E688. https:\/\/doi.org\/10.1097\/MJT.0000000000000695","journal-title":"Am J Ther"},{"key":"1193_CR61","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02559-2020","author":"N Hirani","year":"2021","unstructured":"Hirani N, MacKinnon AC, Nicol L et al (2021) Target inhibition of galectin-3 by inhaled TD139 in patients with idiopathic pulmonary fibrosis. Eur Respir J. https:\/\/doi.org\/10.1183\/13993003.02559-2020","journal-title":"Eur Respir J"},{"key":"1193_CR62","doi-asserted-by":"publisher","DOI":"10.6061\/clinics\/2019\/e225","author":"B Hochhegger","year":"2019","unstructured":"Hochhegger B, Marchiori E, Zanon M et al (2019) Imaging in idiopathic pulmonary fibrosis: diagnosis and mimics. Clinics. https:\/\/doi.org\/10.6061\/clinics\/2019\/e225","journal-title":"Clinics"},{"key":"1193_CR63","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s40265-017-0689-1","volume":"77","author":"SA Holstein","year":"2017","unstructured":"Holstein SA, McCarthy PL (2017) Immunomodulatory drugs in multiple myeloma: mechanisms of action and clinical experience. Drugs 77:505\u2013520. https:\/\/doi.org\/10.1007\/s40265-017-0689-1","journal-title":"Drugs"},{"key":"1193_CR64","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1136\/thx.2008.098699","volume":"63","author":"MR Horton","year":"2008","unstructured":"Horton MR, Danoff SK, Lechtzin N (2008) Thalidomide inhibits the intractable cough of idiopathic pulmonary fibrosis. Thorax 63:749. https:\/\/doi.org\/10.1136\/thx.2008.098699","journal-title":"Thorax"},{"key":"1193_CR65","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1358\/dot.2012.48.10.1855760","volume":"48","author":"MR Horton","year":"2012","unstructured":"Horton MR, Hallowell RW (2012) Revisiting thalidomide: fighting with caution against idiopathic pulmonary fibrosis. Drugs Today 48:661\u2013671. https:\/\/doi.org\/10.1358\/dot.2012.48.10.1855760","journal-title":"Drugs Today"},{"key":"1193_CR66","doi-asserted-by":"publisher","first-page":"398","DOI":"10.7326\/0003-4819-157-6-201209180-00003","volume":"157","author":"MR Horton","year":"2012","unstructured":"Horton MR, Santopietro V, Mathew L et al (2012) Thalidomide for the treatment of cough in idiopathic pulmonary fibrosis: a randomized trial. Ann Intern Med 157:398\u2013406. https:\/\/doi.org\/10.7326\/0003-4819-157-6-201209180-00003","journal-title":"Ann Intern Med"},{"key":"1193_CR67","first-page":"1259","volume":"22","author":"A Hosseini-Chegeni","year":"2019","unstructured":"Hosseini-Chegeni A, Jazaeri F, Yousefi-Ahmadipour A et al (2019) Thalidomide attenuates the hyporesponsiveness of isolated atria to chronotropic stimulation in BDL rats: The involvement of TNF-\u03b1, IL-6 inhibition, and SOCS1 activation. Iran J Basic Med Sci 22:1259\u20131266","journal-title":"Iran J Basic Med Sci"},{"key":"1193_CR68","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3899\/jrheum.161040","volume":"45","author":"VM Hsu","year":"2018","unstructured":"Hsu VM, Denton CP, Domsic RT et al (2018) Pomalidomide in patients with interstitial lung disease due to systemic sclerosis: a phase II, multicenter, randomized, double-blind, placebo-controlled, parallel-group study. J Rheumatol 45:405\u2013410. https:\/\/doi.org\/10.3899\/jrheum.161040","journal-title":"J Rheumatol"},{"key":"1193_CR69","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1007\/s00018-010-0619-9","volume":"68","author":"T Ito","year":"2011","unstructured":"Ito T, Ando H, Handa H (2011) Teratogenic effects of thalidomide: molecular mechanisms. Cell Mol Life Sci 68:1569\u20131579. https:\/\/doi.org\/10.1007\/s00018-010-0619-9","journal-title":"Cell Mol Life Sci"},{"issue":"327","key":"1193_CR70","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1126\/science.1177319","volume":"80","author":"T Ito","year":"2010","unstructured":"Ito T, Ando H, Suzuki T et al (2010) Identification of a primary target of thalidomide teratogenicity. Science 80(327):1345\u20131350. https:\/\/doi.org\/10.1126\/science.1177319","journal-title":"Science"},{"key":"1193_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1741-4520.2011.00351.x","volume":"52","author":"T Ito","year":"2012","unstructured":"Ito T, Handa H (2012) Deciphering the mystery of thalidomide teratogenicity. Congenit Anom (Kyoto) 52:1\u20137. https:\/\/doi.org\/10.1111\/j.1741-4520.2011.00351.x","journal-title":"Congenit Anom (Kyoto)"},{"key":"1193_CR72","doi-asserted-by":"publisher","first-page":"189","DOI":"10.2183\/PJAB.96.016","volume":"96","author":"T Ito","year":"2020","unstructured":"Ito T, Handa H (2020) Molecular mechanisms of thalidomide and its derivatives. Proc Japan Acad Ser B Phys Biol Sci 96:189\u2013203. https:\/\/doi.org\/10.2183\/PJAB.96.016","journal-title":"Proc Japan Acad Ser B Phys Biol Sci"},{"key":"1193_CR73","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.656921","author":"YJ Jung","year":"2021","unstructured":"Jung YJ, Tweedie D, Scerba MT et al (2021) Repurposing immunomodulatory imide drugs (IMiDs) in neuropsychiatric and neurodegenerative disorders. Front Neurosci. https:\/\/doi.org\/10.3389\/fnins.2021.656921","journal-title":"Front Neurosci"},{"key":"1193_CR74","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/s12276-021-00619-6","volume":"53","author":"HJ Kang","year":"2021","unstructured":"Kang HJ, Lee KJ, Woo J et al (2021) Cereblon contributes to the development of pulmonary fibrosis via inactivation of adenosine monophosphate-activated protein kinase \u03b11. Exp Mol Med 53:885\u2013893. https:\/\/doi.org\/10.1038\/s12276-021-00619-6","journal-title":"Exp Mol Med"},{"key":"1193_CR75","doi-asserted-by":"publisher","first-page":"4127","DOI":"10.2147\/DDDT.S393122","volume":"16","author":"Y Kang","year":"2022","unstructured":"Kang Y, Zhang C, He Y et al (2022) Thalidomide attenuates skin lesions and inflammation in rosacea-like mice induced by long-term exposure of LL-37. Drug Des Devel Ther 16:4127\u20134138. https:\/\/doi.org\/10.2147\/DDDT.S393122","journal-title":"Drug Des Devel Ther"},{"key":"1193_CR76","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12931-017-0642-6","volume":"18","author":"M K\u00e4rkk\u00e4inen","year":"2017","unstructured":"K\u00e4rkk\u00e4inen M, Kettunen H-P, Nurmi H et al (2017) Effect of smoking and comorbidities on survival in idiopathic pulmonary fibrosis. Respir Res 18:160. https:\/\/doi.org\/10.1186\/s12931-017-0642-6","journal-title":"Respir Res"},{"key":"1193_CR77","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/cga.12046","volume":"54","author":"Y Kawamura","year":"2014","unstructured":"Kawamura Y, Yamashita T, Yamauchi T et al (2014) Effects of thalidomide on Fgf8, Bmp4 and Hoxa11 expression in the limb bud in Kbl: JW rabbit embryos. Congenit Anom (kyoto) 54:54\u201362. https:\/\/doi.org\/10.1111\/cga.12046","journal-title":"Congenit Anom (kyoto)"},{"key":"1193_CR78","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.3389\/FIMMU.2020.01248\/BIBTEX","volume":"11","author":"A Khalil","year":"2020","unstructured":"Khalil A, Kamar A, Nemer G (2020) Thalidomide-revisited: are COVID-19 patients going to be the latest victims of yet another theoretical drug-repurposing? Front Immunol 11:1248. https:\/\/doi.org\/10.3389\/FIMMU.2020.01248\/BIBTEX","journal-title":"Front Immunol"},{"key":"1193_CR79","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.pnpbp.2017.12.002","volume":"82","author":"MI Khan","year":"2018","unstructured":"Khan MI, Momeny M, Ostadhadi S et al (2018) Thalidomide attenuates development of morphine dependence in mice by inhibiting PI3K\/Akt and nitric oxide signaling pathways. Prog Neuro-Psychopharmacol Biol Psychiatry 82:39\u201348. https:\/\/doi.org\/10.1016\/j.pnpbp.2017.12.002","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"1193_CR80","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.biopha.2016.11.056","volume":"85","author":"MI Khan","year":"2017","unstructured":"Khan MI, Ostadhadi S, Mumtaz F et al (2017) Thalidomide attenuates the development and expression of antinociceptive tolerance to \u03bc-opioid agonist morphine through L-arginine-iNOS and nitric oxide pathway. Biomed Pharmacother 85:493\u2013502. https:\/\/doi.org\/10.1016\/j.biopha.2016.11.056","journal-title":"Biomed Pharmacother"},{"key":"1193_CR81","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00068","author":"D-Y Kim","year":"2020","unstructured":"Kim D-Y, Lee S-H, Fu Y et al (2020) Del-1 an endogenous inhibitor of TGF-\u03b2 activation attenuates fibrosis. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2020.00068","journal-title":"Front Immunol"},{"key":"1193_CR82","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1007\/s00424-016-1854-1","volume":"468","author":"HK Kim","year":"2016","unstructured":"Kim HK, Ko TH, Nyamaa B et al (2016) Cereblon in health and disease. Pfl\u00fcgers Arch - Eur J Physiol 468:1299\u20131309. https:\/\/doi.org\/10.1007\/s00424-016-1854-1","journal-title":"Pfl\u00fcgers Arch - Eur J Physiol"},{"key":"1193_CR83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/toxsci\/kfr088","volume":"122","author":"JH Kim","year":"2011","unstructured":"Kim JH, Scialli AR (2011) Thalidomide: the tragedy of birth defects and the effective treatment of disease. Toxicol Sci 122:1\u20136. https:\/\/doi.org\/10.1093\/toxsci\/kfr088","journal-title":"Toxicol Sci"},{"key":"1193_CR84","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a022293","author":"KK Kim","year":"2018","unstructured":"Kim KK, Sheppard D, Chapman HA (2018) TGF-\u03b21 signaling and tissue fibrosis. Cold Spring Harb Perspect Biol. https:\/\/doi.org\/10.1101\/cshperspect.a022293","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"1193_CR85","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1164\/rccm.201011-1874OC","volume":"184","author":"TE King","year":"2011","unstructured":"King TE, Brown KK, Raghu G et al (2011) BUILD-3: a randomized, controlled trial of bosentan in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 184:92\u201399. https:\/\/doi.org\/10.1164\/rccm.201011-1874OC","journal-title":"Am J Respir Crit Care Med"},{"key":"1193_CR86","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.680217","author":"TW Kowalski","year":"2021","unstructured":"Kowalski TW, Caldas-Garcia GB, Gomes JDA et al (2021) Comparative genomics identifies putative interspecies mechanisms underlying crbn-sall4-linked thalidomide embryopathy. Front Genet. https:\/\/doi.org\/10.3389\/fgene.2021.680217","journal-title":"Front Genet"},{"key":"1193_CR87","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1378\/chest.128.3.1475","volume":"128","author":"H Kubo","year":"2005","unstructured":"Kubo H, Nakayama K, Yanai M et al (2005) Anticoagulant therapy for idiopathic pulmonary fibrosis. Chest 128:1475\u20131482. https:\/\/doi.org\/10.1378\/chest.128.3.1475","journal-title":"Chest"},{"key":"1193_CR88","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.2174\/156802612801784407","volume":"12","author":"N Kumar","year":"2012","unstructured":"Kumar N, Sharma U, Singh C, Singh B (2012) Thalidomide: chemistry, therapeutic potential and oxidative stress induced teratogenicity. Curr Top Med Chem 12:1436\u20131455. https:\/\/doi.org\/10.2174\/156802612801784407","journal-title":"Curr Top Med Chem"},{"key":"1193_CR89","doi-asserted-by":"publisher","first-page":"6539","DOI":"10.1096\/fj.201801766RRR","volume":"33","author":"E Kwon","year":"2019","unstructured":"Kwon E, Li X, Deng Y et al (2019) AMPK is down-regulated by the CRL4A-CRBN axis through the polyubiquitination of AMPK\u03b1 isoforms. FASEB J 33:6539\u20136550. https:\/\/doi.org\/10.1096\/fj.201801766RRR","journal-title":"FASEB J"},{"key":"1193_CR90","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/J.BBAMCR.2011.01.005","volume":"1813","author":"KM Lee","year":"2011","unstructured":"Lee KM, Jo S, Kim H et al (2011) Functional modulation of AMP-activated protein kinase by cereblon. Biochim Biophys Acta Mol Cell Res 1813:448\u2013455. https:\/\/doi.org\/10.1016\/J.BBAMCR.2011.01.005","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"1193_CR91","doi-asserted-by":"publisher","DOI":"10.1186\/s12950-015-0093-0","author":"D Li","year":"2015","unstructured":"Li D, Zhang X-W, Jiang X-Q et al (2015) Protective effects of thalidomide on pulmonary injuries in a rat model of paraquat intoxication. J Inflamm (united Kingdom). https:\/\/doi.org\/10.1186\/s12950-015-0093-0","journal-title":"J Inflamm (united Kingdom)"},{"key":"1193_CR92","doi-asserted-by":"publisher","first-page":"6196","DOI":"10.1080\/21655979.2022.2036913","volume":"13","author":"L Li","year":"2022","unstructured":"Li L, Chen Y, Shi C (2022a) Nintedanib ameliorates oxidized low-density lipoprotein induced inflammation and cellular senescence in vascular endothelial cells. Bioengineered 13:6196\u20136207. https:\/\/doi.org\/10.1080\/21655979.2022.2036913","journal-title":"Bioengineered"},{"key":"1193_CR93","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23105656","author":"Y Li","year":"2022","unstructured":"Li Y, Cai W, Jin F et al (2022b) Thalidomide alleviates pulmonary fibrosis induced by silica in mice by inhibiting ER stress and the TLR4-NF-\u03baB pathway. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23105656","journal-title":"Int J Mol Sci"},{"key":"1193_CR94","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1016\/J.BCP.2013.02.038","volume":"85","author":"CJ Liang","year":"2013","unstructured":"Liang CJ, Yen YH, Hung LY et al (2013) Thalidomide inhibits fibronectin production in TGF-\u03b21-treated normal and keloid fibroblasts via inhibition of the p38\/Smad3 pathway. Biochem Pharmacol 85:1594\u20131602. https:\/\/doi.org\/10.1016\/J.BCP.2013.02.038","journal-title":"Biochem Pharmacol"},{"key":"1193_CR95","doi-asserted-by":"publisher","first-page":"510","DOI":"10.2174\/1570161115666171004123428","volume":"16","author":"JH Liu","year":"2018","unstructured":"Liu JH, Wu HH, Zhao YK et al (2018) Thalidomide improves psoriasis-like lesions and inhibits cutaneous vegf expression without alteration of microvessel density in imiquimod-induced psoriatic mouse model. Curr Vasc Pharmacol 16:510\u2013521. https:\/\/doi.org\/10.2174\/1570161115666171004123428","journal-title":"Curr Vasc Pharmacol"},{"key":"1193_CR96","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/7090534","volume":"2019","author":"Q Liu","year":"2019","unstructured":"Liu Q, Gao Y, Ci X (2019) Role of Nrf2 and its activators in respiratory diseases. Oxid Med Cell Longev 2019:1\u201317. https:\/\/doi.org\/10.1155\/2019\/7090534","journal-title":"Oxid Med Cell Longev"},{"key":"1193_CR97","doi-asserted-by":"publisher","first-page":"669","DOI":"10.3892\/etm.2013.1457","volume":"7","author":"X Liu","year":"2014","unstructured":"Liu X, Qian L, Nan H et al (2014) Function of the transforming growth factor-\u03b21\/c-Jun N-terminal kinase signaling pathway in the action of thalidomide on a rat model of pulmonary fibrosis. Exp Ther Med 7:669\u2013674. https:\/\/doi.org\/10.3892\/etm.2013.1457","journal-title":"Exp Ther Med"},{"key":"1193_CR98","doi-asserted-by":"publisher","first-page":"4829","DOI":"10.1096\/FJ.15-274050\/-\/DC1","volume":"29","author":"Y Liu","year":"2015","unstructured":"Liu Y, Huang X, He X et al (2015) A novel effect of thalidomide and its analogs: Suppression of cereblon ubiquitination enhances ubiquitin ligase function. FASEB J 29:4829\u20134839. https:\/\/doi.org\/10.1096\/FJ.15-274050\/-\/DC1","journal-title":"FASEB J"},{"key":"1193_CR99","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-017-0405-7","author":"Y Liu","year":"2017","unstructured":"Liu Y, Lu F, Kang L et al (2017) Pirfenidone attenuates bleomycin-induced pulmonary fibrosis in mice by regulating Nrf2\/Bach1 equilibrium. BMC Pulm Med. https:\/\/doi.org\/10.1186\/s12890-017-0405-7","journal-title":"BMC Pulm Med"},{"key":"1193_CR100","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1517\/14656566.2013.758250","volume":"14","author":"HK Lota","year":"2013","unstructured":"Lota HK, Wells AU (2013) The evolving pharmacotherapy of pulmonary fibrosis. Expert Opin Pharmacother 14:79\u201389. https:\/\/doi.org\/10.1517\/14656566.2013.758250","journal-title":"Expert Opin Pharmacother"},{"key":"1193_CR101","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/1756-185X.13769","volume":"23","author":"Y Lu","year":"2020","unstructured":"Lu Y, Zhao C, Lei L et al (2020) Effects of thalidomide on Th17, Treg cells and TGF-\u03b21\/Smad3 pathway in a mouse model of systemic sclerosis. Int J Rheum Dis 23:406\u2013419. https:\/\/doi.org\/10.1111\/1756-185X.13769","journal-title":"Int J Rheum Dis"},{"key":"1193_CR102","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12931-021-01711-1","volume":"22","author":"F Luppi","year":"2021","unstructured":"Luppi F, Kalluri M, Faverio P et al (2021) Idiopathic pulmonary fibrosis beyond the lung: understanding disease mechanisms to improve diagnosis and management. Respir Res 22:109. https:\/\/doi.org\/10.1186\/s12931-021-01711-1","journal-title":"Respir Res"},{"key":"1193_CR103","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1159\/000475780","volume":"93","author":"D Magnini","year":"2017","unstructured":"Magnini D, Montemurro G, Iovene B et al (2017) Idiopathic pulmonary fibrosis: molecular endotypes of fibrosis stratifying existing and emerging therapies. Respiration 93:379\u2013395. https:\/\/doi.org\/10.1159\/000475780","journal-title":"Respiration"},{"key":"1193_CR104","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/s12931-021-01791-z","volume":"22","author":"TM Maher","year":"2021","unstructured":"Maher TM, Bendstrup E, Dron L et al (2021) Global incidence and prevalence of idiopathic pulmonary fibrosis. Respir Res 22:197. https:\/\/doi.org\/10.1186\/s12931-021-01791-z","journal-title":"Respir Res"},{"key":"1193_CR105","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.2174\/156802612801784443","volume":"12","author":"S Majumder","year":"2012","unstructured":"Majumder S, Rama Chaitanya Sreedhara S, Banerjee S, Chatterjee S (2012) TNF \u03b1 signaling beholds thalidomide saga: a review of mechanistic role of TNF-\u03b1 signaling under thalidomide. Curr Top Med Chem 12:1456\u20131467. https:\/\/doi.org\/10.2174\/156802612801784443","journal-title":"Curr Top Med Chem"},{"key":"1193_CR106","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1111\/j.1440-1843.2011.01955.x","volume":"16","author":"MA Malouf","year":"2011","unstructured":"Malouf MA, Hopkins P, Snell G, Glanville A (2011) An investigator-driven study of everolimus in surgical lung biopsy confirmed idiopathic pulmonary fibrosis. Respirology 16:776\u2013783. https:\/\/doi.org\/10.1111\/j.1440-1843.2011.01955.x","journal-title":"Respirology"},{"issue":"3","key":"1193_CR107","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2017.74","volume":"31","author":"FJ Martinez","year":"2017","unstructured":"Martinez FJ, Collard HR, Pardo A et al (2017) (2017) Idiopathic pulmonary fibrosis. Nat Rev Dis Prim 31(3):1\u201319. https:\/\/doi.org\/10.1038\/nrdp.2017.74","journal-title":"Nat Rev Dis Prim"},{"key":"1193_CR108","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1056\/NEJM196212132672407","volume":"267","author":"GW Mellin","year":"1962","unstructured":"Mellin GW, Katzenstein M (1962) The saga of thalidomide - neuropathy to embryopathy, with case reports of congenital anomalies. N Engl J Med 267:1238\u20131244. https:\/\/doi.org\/10.1056\/NEJM196212132672407","journal-title":"N Engl J Med"},{"key":"1193_CR109","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.2147\/JIR.S280958","volume":"13","author":"JE Michalski","year":"2020","unstructured":"Michalski JE, Schwartz DA (2020) Genetic risk factors for idiopathic pulmonary fibrosis: Insights into immunopathogenesis. J Inflamm Res 13:1305\u20131318. https:\/\/doi.org\/10.2147\/JIR.S280958","journal-title":"J Inflamm Res"},{"key":"1193_CR110","doi-asserted-by":"publisher","first-page":"2770","DOI":"10.1111\/cas.14538","volume":"111","author":"K Miyazato","year":"2020","unstructured":"Miyazato K, Tahara H, Hayakawa Y (2020) Antimetastatic effects of thalidomide by inducing the functional maturation of peripheral natural killer cells. Cancer Sci 111:2770\u20132778. https:\/\/doi.org\/10.1111\/cas.14538","journal-title":"Cancer Sci"},{"key":"1193_CR111","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1093\/ajhp\/zxab375","volume":"79","author":"LE Morrow","year":"2022","unstructured":"Morrow LE, Hilleman D, Malesker MA (2022) Management of patients with fibrosing interstitial lung diseases. Am J Heal Pharm 79:129\u2013139. https:\/\/doi.org\/10.1093\/ajhp\/zxab375","journal-title":"Am J Heal Pharm"},{"key":"1193_CR112","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12968\/hmed.2020.0556","volume":"82","author":"D Mudawi","year":"2021","unstructured":"Mudawi D, Heyes K, Hastings R et al (2021) An update on interstitial lung disease. Br J Hosp Med 82:1\u201314. https:\/\/doi.org\/10.12968\/hmed.2020.0556","journal-title":"Br J Hosp Med"},{"key":"1193_CR113","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiolchem.2022.107776","author":"U Nayek","year":"2022","unstructured":"Nayek U, Basheer Ahamed SI, Mansoor Hussain UH et al (2022) Computational investigations of indanedione and indanone derivatives in drug discovery: indanone derivatives inhibits cereblon, an E3 ubiquitin ligase component. Comput Biol Chem. https:\/\/doi.org\/10.1016\/j.compbiolchem.2022.107776","journal-title":"Comput Biol Chem"},{"key":"1193_CR114","first-page":"75","volume":"50","author":"M Nematbakhsh","year":"2009","unstructured":"Nematbakhsh M, Rafieyan S, Mirkheshti N et al (2009) Thalidomide reduces the level of nitric oxide in Bleomycin induced pulmonary fibrosis model. Clin Exp Med Lett 50:75\u201376","journal-title":"Clin Exp Med Lett"},{"key":"1193_CR115","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0210222","author":"E Newbronner","year":"2019","unstructured":"Newbronner E, Glendinning C, Atkin K, Wadman R (2019) The health and quality of life of Thalidomide survivors as they age\u2014evidence from a UK survey. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0210222","journal-title":"PLoS ONE"},{"key":"1193_CR116","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201202-0314OC","author":"I Noth","year":"2012","unstructured":"Noth I, Anstrom KJ, Calvert SB et al (2012) A placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. https:\/\/doi.org\/10.1164\/rccm.201202-0314OC","journal-title":"Am J Respir Crit Care Med"},{"key":"1193_CR117","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1684\/ecn.2013.0342","volume":"24","author":"B Piura","year":"2013","unstructured":"Piura B, Medina L, Rabinovich A et al (2013) Thalidomide distinctly affected TNF-\u03b1, IL-6 and MMP secretion by an ovarian cancer cell line (SKOV-3) and primary ovarian cancer cells. Eur Cytokine Netw 24:122\u2013129. https:\/\/doi.org\/10.1684\/ecn.2013.0342","journal-title":"Eur Cytokine Netw"},{"key":"1193_CR118","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1056\/NEJMoa1113354","volume":"366","author":"G Raghu","year":"2012","unstructured":"Raghu G, Anstrom KJ, King TE Jr et al (2012) Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. N Engl J Med 366:1968\u20131977. https:\/\/doi.org\/10.1056\/NEJMoa1113354","journal-title":"N Engl J Med"},{"key":"1193_CR119","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/S2213-2600(19)30172-9","volume":"7","author":"G Raghu","year":"2019","unstructured":"Raghu G, van den Blink B, Hamblin MJ et al (2019) Long-term treatment with recombinant human pentraxin 2 protein in patients with idiopathic pulmonary fibrosis: an open-label extension study. Lancet Respir Med 7:657\u2013664. https:\/\/doi.org\/10.1016\/S2213-2600(19)30172-9","journal-title":"Lancet Respir Med"},{"key":"1193_CR120","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1038\/S41591-018-0087-6","volume":"24","author":"S Rangarajan","year":"2018","unstructured":"Rangarajan S, Bone NB, Zmijewska AA et al (2018) Metformin reverses established lung fibrosis in a bleomycin model. Nat Med 24:1121. https:\/\/doi.org\/10.1038\/S41591-018-0087-6","journal-title":"Nat Med"},{"key":"1193_CR121","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1177\/2040620711413165","volume":"2","author":"W Rehman","year":"2011","unstructured":"Rehman W, Arfons LM, Lazarus HM (2011) The rise, fall and subsequent triumph of thalidomide: lessons learned in drug development. Ther Adv Hematol 2:291. https:\/\/doi.org\/10.1177\/2040620711413165","journal-title":"Ther Adv Hematol"},{"key":"1193_CR122","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1097\/00002030-199611000-00007","volume":"10","author":"G Reyes-Ter\u00e1n","year":"1996","unstructured":"Reyes-Ter\u00e1n G, Sierra-Madero JG, Mart\u00ednez Del Cerro V et al (1996) Effects of thalidomide on HIV-associated wasting syndrome: a randomized, double-blind, placebo-controlled clinical trial. AIDS 10:1501\u20131507. https:\/\/doi.org\/10.1097\/00002030-199611000-00007","journal-title":"AIDS"},{"key":"1193_CR123","doi-asserted-by":"publisher","first-page":"2974","DOI":"10.15419\/bmrat.v6i1.518","volume":"6","author":"MJ Rezaie","year":"2019","unstructured":"Rezaie MJ, Rostamzadeh A, Keshavarz G et al (2019) Effect of Thalidomide on Cox-2 expression in bleomycin-induced pulmonary fibrosis in mice. Biomed Res Ther 6:2974\u20132982. https:\/\/doi.org\/10.15419\/bmrat.v6i1.518","journal-title":"Biomed Res Ther"},{"key":"1193_CR124","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1016\/S0140-6736(17)30866-8","volume":"389","author":"L Richeldi","year":"2017","unstructured":"Richeldi L, Collard HR, Jones MG (2017) Idiopathic pulmonary fibrosis. Lancet 389:1941\u20131952. https:\/\/doi.org\/10.1016\/S0140-6736(17)30866-8","journal-title":"Lancet"},{"key":"1193_CR125","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S2213-2600(19)30262-0","volume":"8","author":"L Richeldi","year":"2020","unstructured":"Richeldi L, Fern\u00e1ndez P\u00e9rez ER, Costabel U et al (2020) Pamrevlumab, an anti-connective tissue growth factor therapy, for idiopathic pulmonary fibrosis (PRAISE): a phase 2, randomised, double-blind, placebo-controlled trial. Lancet Respir Med 8:25\u201333. https:\/\/doi.org\/10.1016\/S2213-2600(19)30262-0","journal-title":"Lancet Respir Med"},{"key":"1193_CR126","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12905-019-0745-y","volume":"19","author":"C Samel","year":"2019","unstructured":"Samel C, Albus C, Nippert I et al (2019) Life situation of women impaired by Thalidomide embryopathy in North Rhine-Westphalia\u2014a comparative analysis of a recent cross-sectional study with earlier data. BMC Womens Health 19:51. https:\/\/doi.org\/10.1186\/s12905-019-0745-y","journal-title":"BMC Womens Health"},{"key":"1193_CR127","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1084\/jem.173.3.699","volume":"173","author":"EP Sampaio","year":"1991","unstructured":"Sampaio EP, Sarno EN, Galilly R et al (1991) Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes. J Exp Med 173:699\u2013703. https:\/\/doi.org\/10.1084\/jem.173.3.699","journal-title":"J Exp Med"},{"key":"1193_CR128","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.jaad.2015.09.039","volume":"74","author":"D Sharma","year":"2016","unstructured":"Sharma D, Kwatra SG (2016) Thalidomide for the treatment of chronic refractory pruritus. J Am Acad Dermatol 74:363\u2013369. https:\/\/doi.org\/10.1016\/j.jaad.2015.09.039","journal-title":"J Am Acad Dermatol"},{"key":"1193_CR129","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1183\/09059180.00010909","volume":"17","author":"D Sheppard","year":"2008","unstructured":"Sheppard D (2008) The role of integrins in pulmonary fibrosis. Eur Respir Rev 17:157\u2013162. https:\/\/doi.org\/10.1183\/09059180.00010909","journal-title":"Eur Respir Rev"},{"key":"1193_CR130","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1002\/cpt196563303","volume":"6","author":"J Sheskin","year":"1965","unstructured":"Sheskin J (1965) Thalidomide in the treatment of lepra reactions. Clin Pharmacol Ther 6:303\u2013306. https:\/\/doi.org\/10.1002\/cpt196563303","journal-title":"Clin Pharmacol Ther"},{"issue":"32","key":"1193_CR131","doi-asserted-by":"publisher","first-page":"4191","DOI":"10.1038\/onc.2012.599","volume":"3236","author":"J Shortt","year":"2013","unstructured":"Shortt J, Hsu AK (2013) Johnstone RW (2013) Thalidomide-analogue biology: immunological, molecular and epigenetic targets in cancer therapy. Oncogene 3236(32):4191\u20134202. https:\/\/doi.org\/10.1038\/onc.2012.599","journal-title":"Oncogene"},{"key":"1193_CR132","doi-asserted-by":"publisher","first-page":"708","DOI":"10.4049\/jimmunol.179.1.708","volume":"179","author":"C Tabata","year":"2007","unstructured":"Tabata C, Tabata R, Kadokawa Y et al (2007) Thalidomide prevents bleomycin-induced pulmonary fibrosis in mice. J Immunol 179:708\u2013714. https:\/\/doi.org\/10.4049\/jimmunol.179.1.708","journal-title":"J Immunol"},{"key":"1193_CR133","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.cbi.2015.05.017","volume":"238","author":"R Talaat","year":"2015","unstructured":"Talaat R, El-Sayed W, Agwa HS et al (2015) Anti-inflammatory effect of thalidomide dithiocarbamate and dithioate analogs. Chem Biol Interact 238:74\u201381. https:\/\/doi.org\/10.1016\/j.cbi.2015.05.017","journal-title":"Chem Biol Interact"},{"key":"1193_CR134","doi-asserted-by":"publisher","first-page":"5207","DOI":"10.1007\/s00018-020-03465-3","volume":"77","author":"C-T Tang","year":"2020","unstructured":"Tang C-T, Zhang Q-W, Wu S et al (2020) Thalidomide targets EGFL6 to inhibit EGFL6\/PAX6 axis-driven angiogenesis in small bowel vascular malformation. Cell Mol Life Sci 77:5207\u20135221. https:\/\/doi.org\/10.1007\/s00018-020-03465-3","journal-title":"Cell Mol Life Sci"},{"key":"1193_CR135","doi-asserted-by":"publisher","first-page":"3589","DOI":"10.1039\/D0NJ03139A","volume":"45","author":"KW Tang","year":"2021","unstructured":"Tang KW, Hsu WL, Chen CR et al (2021) Discovery of triazolyl thalidomide derivatives as anti-fibrosis agents. New J Chem 45:3589\u20133599. https:\/\/doi.org\/10.1039\/D0NJ03139A","journal-title":"New J Chem"},{"key":"1193_CR136","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1080\/17476348.2021.1916472","volume":"15","author":"SE Tanni","year":"2021","unstructured":"Tanni SE, Fabro AT, de Albuquerque A et al (2021) Pulmonary fibrosis secondary to COVID-19: a narrative review. Expert Rev Respir Med 15:791\u2013803. https:\/\/doi.org\/10.1080\/17476348.2021.1916472","journal-title":"Expert Rev Respir Med"},{"key":"1193_CR137","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1182\/blood.2019003749","volume":"135","author":"T Tochigi","year":"2020","unstructured":"Tochigi T, Miyamoto T, Hatakeyama K et al (2020) Aromatase is a novel neosubstrate of cereblon responsible for immunomodulatory drug-induced thrombocytopenia. Blood 135:2146\u20132158. https:\/\/doi.org\/10.1182\/blood.2019003749","journal-title":"Blood"},{"key":"1193_CR138","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1755-1536-5-11","volume":"5","author":"NW Todd","year":"2012","unstructured":"Todd NW, Luzina IG, Atamas SP (2012) Molecular and cellular mechanisms of pulmonary fibrosis. Fibrogenesis Tissue Repair 5:11. https:\/\/doi.org\/10.1186\/1755-1536-5-11","journal-title":"Fibrogenesis Tissue Repair"},{"key":"1193_CR139","doi-asserted-by":"publisher","first-page":"17131","DOI":"10.1038\/s41598-018-35457-6","volume":"8","author":"E Tokunaga","year":"2018","unstructured":"Tokunaga E, Yamamoto T, Ito E, Shibata N (2018) Understanding the thalidomide chirality in biological processes by the self-disproportionation of enantiomers. Sci Rep 8:17131. https:\/\/doi.org\/10.1038\/s41598-018-35457-6","journal-title":"Sci Rep"},{"key":"1193_CR140","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/S2213-2600(20)30122-3","volume":"8","author":"S Tomassetti","year":"2020","unstructured":"Tomassetti S, Ravaglia C, Wells AU et al (2020) Prognostic value of transbronchial lung cryobiopsy for the multidisciplinary diagnosis of idiopathic pulmonary fibrosis: a retrospective validation study. Lancet Respir Med 8:786\u2013794. https:\/\/doi.org\/10.1016\/S2213-2600(20)30122-3","journal-title":"Lancet Respir Med"},{"key":"1193_CR141","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/J.AB.2016.10.021","volume":"524","author":"D Tsikas","year":"2017","unstructured":"Tsikas D (2017) Assessment of lipid peroxidation by measuring malondialdehyde (MDA) and relatives in biological samples: analytical and biological challenges. Anal Biochem 524:13\u201330. https:\/\/doi.org\/10.1016\/J.AB.2016.10.021","journal-title":"Anal Biochem"},{"key":"1193_CR142","doi-asserted-by":"publisher","first-page":"e0226785","DOI":"10.1371\/journal.pone.0226785","volume":"15","author":"AA van Batenburg","year":"2020","unstructured":"van Batenburg AA, Kazemier KM, van Oosterhout MFM et al (2020) From organ to cell: Multi-level telomere length assessment in patients with idiopathic pulmonary fibrosis. PLoS ONE 15:e0226785. https:\/\/doi.org\/10.1371\/journal.pone.0226785","journal-title":"PLoS ONE"},{"key":"1193_CR143","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2021.102125","author":"R van Toorn","year":"2021","unstructured":"van Toorn R, Zaharie S-D, Seddon JA et al (2021) The use of thalidomide to treat children with tuberculosis meningitis: a review. Tuberculosis. https:\/\/doi.org\/10.1016\/j.tube.2021.102125","journal-title":"Tuberculosis"},{"key":"1193_CR144","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1002\/bdrc.21096","volume":"105","author":"N Vargesson","year":"2015","unstructured":"Vargesson N (2015) Thalidomide-induced teratogenesis: history and mechanisms. Birth Defects Res Part C Embryo Today Rev 105:140\u2013156. https:\/\/doi.org\/10.1002\/bdrc.21096","journal-title":"Birth Defects Res Part C Embryo Today Rev"},{"key":"1193_CR145","doi-asserted-by":"publisher","first-page":"120283","DOI":"10.1016\/j.lfs.2021.120283","volume":"291","author":"V Velagacherla","year":"2022","unstructured":"Velagacherla V, Mehta CH, Nayak Y, Nayak UY (2022) Molecular pathways and role of epigenetics in the idiopathic pulmonary fibrosis. Life Sci 291:120283. https:\/\/doi.org\/10.1016\/j.lfs.2021.120283","journal-title":"Life Sci"},{"key":"1193_CR146","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1089\/ars.2007.1901","volume":"10","author":"DM Walters","year":"2008","unstructured":"Walters DM, Cho H-Y, Kleeberger SR (2008) Oxidative stress and antioxidants in the pathogenesis of pulmonary fibrosis: a potential role for Nrf2. Antioxidants Redox Signal 10:321\u2013332. https:\/\/doi.org\/10.1089\/ars.2007.1901","journal-title":"Antioxidants Redox Signal"},{"key":"1193_CR147","doi-asserted-by":"publisher","first-page":"5318","DOI":"10.1080\/21655979.2022.2036899","volume":"13","author":"C Wang","year":"2022","unstructured":"Wang C, Qu L (2022) The anti-fibrotic agent nintedanib protects chondrocytes against tumor necrosis factor-\u0251 (TNF-\u0251)-induced extracellular matrix degradation. Bioengineered 13:5318\u20135329. https:\/\/doi.org\/10.1080\/21655979.2022.2036899","journal-title":"Bioengineered"},{"key":"1193_CR148","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1007\/s10753-020-01378-8","volume":"44","author":"L Wang","year":"2021","unstructured":"Wang L, Wang S, Xue A et al (2021) Thalidomide inhibits angiogenesis via downregulation of VEGF and angiopoietin-2 in Crohn\u2019s Disease. Inflammation 44:795\u2013807. https:\/\/doi.org\/10.1007\/s10753-020-01378-8","journal-title":"Inflammation"},{"key":"1193_CR149","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11091685","author":"Y Wang","year":"2022","unstructured":"Wang Y, Wei J, Deng H et al (2022) The role of Nrf2 in pulmonary fibrosis: molecular mechanisms and treatment approaches. Antioxidants. https:\/\/doi.org\/10.3390\/antiox11091685","journal-title":"Antioxidants"},{"key":"1193_CR150","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/MI.2008.85","volume":"2","author":"M Wilson","year":"2009","unstructured":"Wilson M, Wynn T (2009) Pulmonary fibrosis: pathogenesis, etiology and regulation. Mucosal Immunol 2:103. https:\/\/doi.org\/10.1038\/MI.2008.85","journal-title":"Mucosal Immunol"},{"key":"1193_CR151","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.948101","author":"X Wu","year":"2022","unstructured":"Wu X, Xiao X, Chen X et al (2022) Effectiveness and mechanism of metformin in animal models of pulmonary fibrosis: a preclinical systematic review and meta-analysis. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2022.948101","journal-title":"Front Pharmacol"},{"key":"1193_CR152","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.21037\/apm-19-398","volume":"9","author":"Y Wu","year":"2020","unstructured":"Wu Y, Liu L, Zhang J et al (2020) Thalidomide inhibits the gene promoter of connective tissue growth factor in human embryonic lung fibroblasts. Ann Palliat Med 9:2516\u20132523. https:\/\/doi.org\/10.21037\/apm-19-398","journal-title":"Ann Palliat Med"},{"key":"1193_CR153","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1159\/000504763","volume":"99","author":"WA Wuyts","year":"2020","unstructured":"Wuyts WA, Wijsenbeek M, Bondue B et al (2020) Idiopathic pulmonary fibrosis: best practice in monitoring and managing a relentless fibrotic disease. Respiration 99:73\u201382. https:\/\/doi.org\/10.1159\/000504763","journal-title":"Respiration"},{"key":"1193_CR154","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.818839","author":"J Xie","year":"2022","unstructured":"Xie J, Zhang C, Li S et al (2022) Efficacy and safety of thalidomide as a pre-medication of chemotherapy-induced nausea and vomiting (CINV) following highly emetogenic chemotherapy (hec): a systematic review and meta-analysis. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2021.818839","journal-title":"Front Oncol"},{"key":"1193_CR155","doi-asserted-by":"publisher","first-page":"109761","DOI":"10.1016\/J.BIOPHA.2019.109761","volume":"123","author":"H Yang","year":"2020","unstructured":"Yang H, Song Z, Hong D (2020) CRBN knockdown mitigates lipopolysaccharide-induced acute lung injury by suppression of oxidative stress and endoplasmic reticulum (ER) stress associated NF-\u03baB signaling. Biomed Pharmacother 123:109761. https:\/\/doi.org\/10.1016\/J.BIOPHA.2019.109761","journal-title":"Biomed Pharmacother"},{"key":"1193_CR156","doi-asserted-by":"publisher","DOI":"10.3390\/ph14060512","author":"S-J Yang","year":"2021","unstructured":"Yang S-J, Jeon S, Baek JW et al (2021) Regulation of AMPK activity by CRBN is independent of the thalidomide-CRL4CRBN protein degradation axis. Pharmaceuticals. https:\/\/doi.org\/10.3390\/ph14060512","journal-title":"Pharmaceuticals"},{"key":"1193_CR157","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1183\/09031936.06.00131505","volume":"28","author":"Q Ye","year":"2006","unstructured":"Ye Q (2006) Thalidomide reduces IL-18, IL-8 and TNF- release from alveolar macrophages in interstitial lung disease. Eur Respir J 28:824\u2013831. https:\/\/doi.org\/10.1183\/09031936.06.00131505","journal-title":"Eur Respir J"},{"key":"1193_CR158","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2021.4965","author":"Z Ye","year":"2021","unstructured":"Ye Z, Hu Y (2021) TGF-\u03b21: Gentlemanly orchestrator in idiopathic pulmonary fibrosis (review). Int J Mol Med. https:\/\/doi.org\/10.3892\/ijmm.2021.4965","journal-title":"Int J Mol Med"},{"key":"1193_CR159","doi-asserted-by":"publisher","first-page":"89","DOI":"10.2147\/DDDT.S149298","volume":"12","author":"H Zhang","year":"2018","unstructured":"Zhang H, Yang Y, Wang Y et al (2018) Renal-protective effect of thalidomide in streptozotocin-induced diabetic rats through anti-inflammatory pathway. Drug Des Devel Ther 12:89. https:\/\/doi.org\/10.2147\/DDDT.S149298","journal-title":"Drug Des Devel Ther"},{"key":"1193_CR160","first-page":"622","volume":"33","author":"L Zhang","year":"2012","unstructured":"Zhang L, Yang W-L (2012) Effect of thalidomide on the expressions of IL-6, TNF-\u03b1 and TGF-\u03b2 1 in BALF of elder patients with idiopathic pulmonary fibrosis. J xi\u2019an Jiaotong Univ (medical) Sci. 33:622\u2013625","journal-title":"J xi\u2019an Jiaotong Univ (medical) Sci."},{"key":"1193_CR161","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/j.1365-2249.2009.03962.x","volume":"157","author":"L Zhao","year":"2009","unstructured":"Zhao L, Xiao K, Wang H et al (2009) Thalidomide has a therapeutic effect on interstitial lung fibrosis: evidence from in vitro and in vivo studies. Clin Exp Immunol 157:310\u2013315. https:\/\/doi.org\/10.1111\/j.1365-2249.2009.03962.x","journal-title":"Clin Exp Immunol"},{"key":"1193_CR162","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1111\/bcpt.13505","volume":"128","author":"F Zheng","year":"2021","unstructured":"Zheng F, Zhu J, Zhang W et al (2021) Thal protects against paraquat-induced lung injury through a microRNA-141\/HDAC6\/I\u03baB\u03b1-NF-\u03baB axis in rat and cell models. Basic Clin Pharmacol Toxicol 128:334\u2013347. https:\/\/doi.org\/10.1111\/bcpt.13505","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"7","key":"1193_CR163","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-15239-2","volume":"71","author":"XL Zhou","year":"2017","unstructured":"Zhou XL, Xu P, Chen HH et al (2017) (2017) Thalidomide inhibits TGF-\u03b21-induced epithelial to mesenchymal transition in alveolar epithelial cells via smad-dependent and smad-independent signaling pathways. Sci Reports 71(7):1\u201310. https:\/\/doi.org\/10.1038\/s41598-017-15239-2","journal-title":"Sci Reports"},{"key":"1193_CR164","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1007\/s10753-014-9943-9","volume":"37","author":"H Zhu","year":"2014","unstructured":"Zhu H, Shi X, Ju D et al (2014) Anti-Inflammatory effect of thalidomide on h1n1 influenza virus-induced pulmonary injury in mice. Inflammation 37:2091\u20132098. https:\/\/doi.org\/10.1007\/s10753-014-9943-9","journal-title":"Inflammation"},{"key":"1193_CR165","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.712147","author":"N Zhu","year":"2021","unstructured":"Zhu N, Wang L, Guo H et al (2021) Thalidomide suppresses angiogenesis through the signal transducer and activator of transcription 3\/SP4 signaling pathway in the peritoneal membrane. Front Physiol. https:\/\/doi.org\/10.3389\/fphys.2021.712147","journal-title":"Front Physiol"},{"key":"1193_CR166","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1056\/NEJMoa1002110","volume":"363","author":"DA Zisman","year":"2010","unstructured":"Zisman DA, Schwarz M, Anstrom KJ et al (2010) A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis. N Engl J Med 363:620\u2013628. https:\/\/doi.org\/10.1056\/NEJMoa1002110","journal-title":"N Engl J Med"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-023-01193-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-023-01193-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-023-01193-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T05:51:06Z","timestamp":1685425866000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-023-01193-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,25]]},"references-count":166,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["1193"],"URL":"https:\/\/doi.org\/10.1007\/s10787-023-01193-1","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,25]]},"assertion":[{"value":"10 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence in publishing this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"There was no human or animal studies involved.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}